Folate-XTEN-Doxorubicin

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameFolate-XTEN-Doxorubicin
Drug Alias Namefolate doxorubicin conjugate (Amunix)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFolic acid transporters modulatorsVirus DNA polymerase inhibitorsDNA topoisomerase I inhibitors
TargetsVirus DNA polymeraseFolic acid transportersDNA topoisomerase I
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmunix Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmunix Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A